KOFU, JAPAN--August 5, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--Major Japanese pharmaceutical companies are producing active pharmaceutical ingredients (API) and/or performing fill-and-finish services at plants that produce COVID-19 vaccines. Projects range from grassroot developments at contract manufacturing organization (CMO) plants, to expansions at a variety of existing plants.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
